National Institute of Allergy and Infectious Diseases (NIAID)
4
Pharmacia
4
Abbott
3
Glaxo Wellcome
3
Gilead Sciences
2
Pfizer
2
Sandoz
2
Agouron Pharmaceuticals
1
Boehringer Ingelheim
1
GlaxoSmithKline
1
Hoffmann-La Roche
1
Clinical Trials at Infectious Disease Physicians Inc
During the past decade, Infectious Disease Physicians Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
Completed
32
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infectious Disease Physicians Inc" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials, followed by "Pharmacia" with 4 trials
sponsored, "Abbott" with 3 trials sponsored, "Glaxo Wellcome" with 3 trials sponsored and "Gilead Sciences"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Disease Physicians Inc"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Infectious Disease Physicians Inc
According to Clinical.Site data, the most researched conditions in "Infectious Disease Physicians Inc" are
"HIV Infections" (28 trials), "Cytomegalovirus Retinitis" (2 trials), "Diarrhea" (2 trials), "Mycobacterium Avium-Intracellulare Infection" (2 trials) and "Bone Infection" (1 trials). Many other conditions were trialed in "Infectious Disease Physicians Inc" in a lesser frequency.
Clinical Trials Intervention Types at Infectious Disease Physicians Inc
Most popular intervention types in "Infectious Disease Physicians Inc" are "Drug" (26 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (5 trials), "Lamivudine" (3 trials), "Lopinavir/Ritonavir" (3 trials), "Nelfinavir mesylate" (3 trials) and "Nevirapine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Infectious Disease Physicians Inc
The vast majority of trials in "Infectious Disease Physicians Inc" are
29 trials for "All" genders.
Clinical Trials Status at Infectious Disease Physicians Inc
Currently, there are NaN active trials in "Infectious Disease Physicians Inc".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in Infectious Disease Physicians Inc,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Infectious Disease Physicians Inc, 3 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 11 trials that are defined as “Not Applicable".